Angiotensin-like and antagonistic activities of N-terminal modified (8-leucine)angiotensin II peptides.
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001665:Binding Sites; D001794:Blood Pressure / Q000187:drug effects; D002852:Chromatography, Ion Exchange; D002855:Chromatography, Thin Layer; D004590:Electrophoresis, Paper; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006632:Histamine / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007930:Leucine / Q000138:chemical synthesis / Q000494:pharmacology; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D010121:Oxytocin / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship; D014599:Uterus / Q000187:drug effects
D000804:Angiotensin II; D010121:Oxytocin; D006632:Histamine; D007930:Leucine; D004837:Epinephrine